AU Patent

AU2019299538B2 — Testosterone and estradiol transdermal spray

Assigned to Celista Pharmaceuticals LLC · Expires 2025-05-08 · 1y expired

What this patent protects

The invention relates to a sprayable liquid composition for transdermal delivery of testosterone and/or estradiol, and to methods of treatment using this composition.

USPTO Abstract

The invention relates to a sprayable liquid composition for transdermal delivery of testosterone and/or estradiol, and to methods of treatment using this composition.

Drugs covered by this patent

Androgel (TESTOSTERONE) · Besins Hlthcare

Patent Metadata

Patent number: AU2019299538B2
Jurisdiction: AU
Classification: —
Expires: 2025-05-08
Drug substance claim: No
Drug product claim: No
Assignee: Celista Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.